Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.65 USD | +2.52% | 0.00% | -56.18% |
Jun. 04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
Chart calendar Inhibrx, Inc.
Upcoming events on Inhibrx, Inc.
Past events on Inhibrx, Inc.
2024-02-28 09:15 am | Q4 2023 Earnings Release |
2023-11-09 04:00 pm | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract: 742 |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract: 748 |
2023-11-02 12:30 pm | Connective Tissue Oncology Society Meeting |
2023-08-07 04:00 pm | Q2 2023 Earnings Release |
2023-05-25 01:00 pm | Annual General Meeting |
2023-05-08 04:05 pm | Q1 2023 Earnings Release |
2023-03-06 04:05 pm | Q4 2022 Earnings Release |
2022-11-30 11:45 am | Evercore ISI HealthCONx Conference |
2022-11-19 04:36 pm | Connective Tissue Oncology Society Meeting - Abstract: 2206531 |
2022-11-17 05:00 pm | Connective Tissue Oncology Society Meeting - Abstract: 2206600 |
2022-11-17 05:00 pm | Connective Tissue Oncology Society Meeting - Abstract: 2206541 |
2022-11-15 | Connective Tissue Oncology Society Conference |
2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract: 1077 |
2022-11-10 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract: 1077 |
2022-11-07 04:05 pm | Q3 2022 Earnings Release |
2022-11-01 08:30 am | American Conference on Pharmacometrics Meeting - Abstract ID: PMX436 |
2022-10-04 08:30 am | INBRX-101 Update Call |
2022-08-07 | Interim 2022 Earnings Release (Projected) |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 12,9 11,1 16.11% | 7,23 6,10 18.54% | 2,19 2,60 -15.69% | 1,80 0,25 620% | 0,00 |
EBITDA Million USD | Released Forecast Spread | -66,4 -70,7 6.03% | -75,4 -78,0 3.37% | -128 -125 -2.31% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -67,4 -71,8 6% | -76,6 -78,2 2.06% | -129 -126 -2.15% | -219 -178 -23.47% | -304 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -75,6 -81,5 7.14% | -81,8 -82,9 1.38% | -145 -135 -7.34% | -240 -197 -21.5% | -314 |
Net income Million USD | Released Forecast Spread | -76,1 -81,7 6.82% | -81,8 -82,9 1.38% | -145 -139 -4.59% | -241 -197 -22.33% | -316 |
EPS USD | Released Forecast Spread | -3,01 -2,95 -2.21% | -2,15 -2,15 0.19% | -3,62 -3,36 -7.67% | -5,12 -4,39 -16.54% | -5,87 |
Announcement Date | 12/03/21 | 28/02/22 | 06/03/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,93 1,10 -15.8% | 0,71 1,07 -33.55% | 0,28 0,57 -50.94% | 0,27 0,79 -65.46% | 0,02 0,10 -83% | 0,03 0,00 - | 0,12 0,00 - | 1,63 0,05 3168% | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -29,0 -23,3 -24.38% | -34,6 -29,5 -17.42% | -30,0 -36,1 16.83% | -35,5 -32,8 -8.29% | -43,8 -36,0 -21.52% | -41,3 -43,2 4.21% | -45,8 -43,2 -6.05% | -88,3 -46,6 -89.33% | -73,8 -47,9 -54.22% | -74,7 | -76,7 | -78,6 | -82,0 | -90,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,3 -24,4 -28.17% | -37,7 -33,0 -14.43% | -35,3 -39,6 10.7% | -40,9 -33,0 -24.06% | -48,9 -36,9 -32.49% | -47,0 -45,0 -4.52% | -51,8 -46,0 -12.67% | -92,0 -49,5 -85.69% | -78,7 -47,9 -64.42% | -77,1 | -79,1 | -81,0 | -82,0 | -90,5 |
Net income Million USD | Released Forecast Spread | -31,3 -24,4 -28.17% | -37,7 -33,0 -14.44% | -35,3 -39,6 10.7% | -40,9 -33,0 -24.05% | -48,9 -36,9 -32.49% | -47,1 -45,0 -4.53% | -51,8 -46,0 -12.67% | -93,6 -49,5 -88.98% | -78,7 -47,9 -64.42% | -77,1 | -79,1 | -81,0 | -82,0 | -90,5 |
EPS USD | Released Forecast Spread | -0,80 -0,60 -33.33% | -0,97 -0,78 -24.76% | -0,90 -0,94 4.26% | -0,95 -0,79 -20.63% | -1,12 -0,84 -32.81% | -1,08 -1,03 -4.52% | -1,10 -1,01 -8.91% | -1,73 -1,04 -66.88% | -1,44 -1,01 -42.57% | -1,52 | -1,48 | -1,44 | -1,41 | -1,55 |
Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 08/05/23 | 07/08/23 | 09/11/23 | 28/02/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Inhibrx, Inc.
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- INBX Stock
- Calendar Inhibrx, Inc.